Covalon Technologies announces fiscal 2009 third-quarter results

NewsGuard 100/100 Score

Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year. Total operating expenses excluding product were $1,339,495 for the three months ended June 30, 2009 a decrease of $559,691 from the three months ended March 31, 2009. At June 30, 2009, the Company had $7.8 million in cash and cash equivalents available for use.

Mr. Peter Hobbes, Covalon's Chief Financial Officer commented, "Covalon recently made the right decision to discontinue any attempt at building a custom manufacturing capability and instead focus on our core competencies of innovating and developing new products and technologies. This was a key factor in significantly reducing our operating expenses from the second quarter to the third quarter of fiscal 2009."

Dr. Frank DiCosmo, Covalon Co-Founder, President and Chief Executive Officer stated, "The past quarter and this summer has been extremely busy for all of us at Covalon. We have been working non-stop on a number of new initiatives at the same time as diligently continuing our efforts on existing projects. We anticipate that both these streams of effort will lead to some significant long term business for Covalon. We expect to be in a position to provide further information to our shareholders about significant initiatives in the coming weeks."

The Company has also announced the departure of Dr. Sonia Sanhueza as Chief Operations Officer. The Company feels that it can be more efficient and further reduce its expenses by not continuing to have someone hold such a position at this time given the decision taken to not build its own custom manufacturing facility.

http://www.covalon.com 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers develop new way to make vegan food more appetizing